Causes and Consequences of Primary Ovarian Insufficiency
NCT04082169 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2019-09-09
Summary
100 women with primary ovarian insufficiency will be included for extensive diagnostic workup to improve diagnostic precision by extended autoantibody screening and genetic and toxicological testing.
Conditions
- Primary Ovarian Insufficiency
- Premature Menopause
Sponsors & Collaborators
-
Haukeland University Hospital
lead OTHER
Principal Investigators
-
Kahtan Al-Azawy, MD · Haukeland University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-01-11
- Primary Completion
- 2021-12-31
- Completion
- 2022-12-31
Countries
- Norway
Study Locations
More Related Trials
-
Effect of Premature Luteinization on the Oocyte Quality in Oocyte Donation Program.
NCT00455949 ·Status: COMPLETED
-
Ovarian Follicle Function in Patients With Primary Ovarian Failure
NCT00001275 ·Status: COMPLETED
-
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
NCT01340521 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure
NCT00732693 ·Status: COMPLETED ·Phase: PHASE4
-
Follicle Activation by Inhibition of the Hippo Pathway
NCT02792569 ·Status: COMPLETED ·Phase: NA
-
A Non-interventional Study to Identify the Patients With Severe Luteinizing Hormone Deficiency in the Daily Practice
NCT01112618 ·Status: COMPLETED
-
To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation
NCT01029470 ·Status: UNKNOWN ·Phase: PHASE2
-
Therapeutic Endometrial Biopsy
NCT01963819 ·Status: UNKNOWN ·Phase: NA
-
Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI
NCT02477566 ·Status: UNKNOWN ·Phase: NA
-
Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy
NCT00507780 ·Status: WITHDRAWN ·Phase: PHASE4
-
Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders
NCT01732094 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders
NCT05405686 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count
NCT00231504 ·Status: COMPLETED
-
Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study
NCT01921166 ·Status: COMPLETED ·Phase: PHASE4
-
Screening Women for Functional Hypothalamic Amenorrhea (FHA)
NCT05410886 ·Status: COMPLETED
-
Relationship Between Fertility Hormone Patterns and Pregnancy Rates.
NCT05033366 ·Status: ENROLLING_BY_INVITATION
-
hCG Priming in Women With Low Ovarian Reserve
NCT04643925 ·Status: COMPLETED ·Phase: PHASE4
-
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
NCT01606709 ·Status: TERMINATED ·Phase: PHASE4
-
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
NCT05440617 ·Status: RECRUITING
-
Prospective Study of an Human Endometrial Receptivity Test
NCT04192396 ·Status: COMPLETED
-
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
NCT01206803 ·Status: COMPLETED
-
hCG Priming in Women With Diminished Ovarian Reserve
NCT07108621 ·Status: RECRUITING ·Phase: PHASE3
-
Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
NCT02200952 ·Status: COMPLETED
-
A Phase IV, Prospective, Observational, Open Label, Single Centre Cohort Trial to be Conducted in Norway During One Year to Assess the Cumulative Pregnancy Rate in a New Series of In-vitro Fertilization (IVF) Treatment Cycles Following Three or More Previous IVF Treatment Cycles Without Live Birth
NCT01071148 ·Status: COMPLETED
-
Anti-Mullerian Hormone (AMH) and Antral Follicle Count as Markers of Ovarian Reserve- Prospective Followup of Young Cancer Patients
NCT00930501 ·Status: UNKNOWN